Literature DB >> 29936228

Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.

Nima Razzaghi-Asl1, Sahar Mirzayi1, Karim Mahnam2, Saghi Sepehri3.   

Abstract

In an attempt to identify potential COX-2 inhibitors, a multi-step virtual screening strategy was performed on a series of compounds. For this purpose, ZINC database was screened on the basis of 50% structural similarity with celecoxib and indomethacin as the representative of COX-2 and COX-1/COX-2 inhibitors, respectively. Selected molecules were subjected to various filters such as Lipinski's rule of five and also several ADME parameters. Toxicity risk of molecules was approximated via in silico methods. Moreover, COX-2 inhibitory activities of the selected compounds were predicted using PASS program. Molecular docking was performed to improve the accuracy of screening and also to find the details of the interactions of the hit compounds with the active site. Finally, MD simulations on top-ranked structures ZINC_1130464, ZINC_3181760, ZINC_33402495 and celecoxib were carried out with COX-2. Furthermore, RMSD, RMSF, hydrogen binds, Rg and energy analysis during MD simulation certainly indicated the stable binding of selected compounds with COX-2 structure. Moreover, docking and MD results revealed that hydrophobic contacts and optimum hydrogen bonds were determinant factors in the interactions of in silico hits and COX-2.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADMET; COX-2 inhibitor; Molecular dynamic; PASS; Virtual screening

Mesh:

Substances:

Year:  2018        PMID: 29936228     DOI: 10.1016/j.jmgm.2018.05.010

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  6 in total

1.  HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies.

Authors:  Chanin Sillapachaiyaporn; Siriporn Chuchawankul
Journal:  J Tradit Complement Med       Date:  2019-08-01

2.  Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity.

Authors:  Renata Priscila Barros de Menezes; Jéssika de Oliveira Viana; Eugene Muratov; Luciana Scotti; Marcus Tullius Scotti
Journal:  Curr Issues Mol Biol       Date:  2022-01-15       Impact factor: 2.976

3.  De Novo design of potential inhibitors against SARS-CoV-2 Mpro.

Authors:  Shimeng Li; Lianxin Wang; Jinhui Meng; Qi Zhao; Li Zhang; Hongsheng Liu
Journal:  Comput Biol Med       Date:  2022-06-15       Impact factor: 6.698

4.  Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2.

Authors:  Sinthyia Ahmed; Rumana Mahtarin; Sayeda Samina Ahmed; Shaila Akter; Md Shamiul Islam; Abdulla Al Mamun; Rajib Islam; Md Nayeem Hossain; Md Ackas Ali; Mossammad U C Sultana; Md Rimon Parves; M Obayed Ullah; Mohammad A Halim
Journal:  J Biomol Struct Dyn       Date:  2020-07-28

5.  In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors.

Authors:  Nima Razzaghi-Asl; Sahar Mirzayi; Karim Mahnam; Vahed Adhami; Saghi Sepehri
Journal:  Res Pharm Sci       Date:  2022-01-15

6.  Screening of Potential Breast Cancer Inhibitors through Molecular Docking and Molecular Dynamics Simulation.

Authors:  Sangavi Pandi; Langeswaran Kulanthaivel; Gowtham Kumar Subbaraj; Sangeetha Rajaram; Senthilkumar Subramanian
Journal:  Biomed Res Int       Date:  2022-06-28       Impact factor: 3.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.